Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Cash Flow Reinvestment Rate
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. cash flow reinvestment rate. Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Cash Flow Reinvestment Rate of 16.10x as of December 2023, reinvesting CN¥1.46 Billion (capex CN¥688.60 Million plus investments CN¥-767.42 Million) from operating cash flow of CN¥90.45 Million. Explore 301096 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2023)
Cash flow reinvestment rate of Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. from 2019 to 2023. Historical reinvestment intensity for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. across 5 annual periods. Explore Hangzhou Bio-Sincerity Pharma-Tech Co.Lt capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Cash Flow Reinvestment Rate by Year (2019–2023)
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. cash flow reinvestment rate by year from 2019 to 2023. Year-by-year capital reinvestment analysis for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. For the full cash flow conversion analysis, see 301096 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 16.10x | CN¥1.46 Billion | CN¥90.45 Million | CN¥688.60 Million | ▲ +225.6% |
| 2022 | 4.94x | CN¥1.28 Billion | CN¥259.41 Million | CN¥591.58 Million | ▲ +43.9% |
| 2021 | 3.44x | CN¥499.61 Million | CN¥145.42 Million | CN¥248.45 Million | ▼ -63.4% |
| 2020 | 9.40x | CN¥510.91 Million | CN¥54.36 Million | CN¥255.12 Million | ▲ +217.8% |
| 2019 | 2.96x | CN¥211.38 Million | CN¥71.47 Million | CN¥106.95 Million | — |